机构:[1]Breast Disease Center, The First Affiliated Hospital, Sun Yat-sen University,Guangzhou, China中山大学附属第一医院[2]Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA[3]Institute of Precision Medicine, The First Afiliated Hospital, Sun Yat-sen University, Guangzhou, China[4]Department of Breast Oncology, Traditional Chinese Medicine Hospital of Guangdong Province, Guangzhou, Guangdong, China.大德路总院乳腺科大德路总院乳腺科广东省中医院[5]Department of Pathology, The First Afiliated Hospital, Sun Yat-sen University, Guangzhou, China[6]Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.[7]Department of Breast Oncology, Jiangmen Central Hospital, Jiangmen, China.[8]Department of Breast Oncology, Maternal and Child Health Care Hospital of Guangdong Province, Guangzhou, China.[9]Department of Breast Oncology, Jieyang People's Hospital, Jieyang, China.
Inflammatory breast cancer (IBC) is a highly aggressive subtype of breast cancer characterized by rapidly arising diffuse erythema and edema. Genomic studies have not identified consistent alterations and mechanisms that differentiate IBC from non-IBC tumors, suggesting that the microenvironment could be a potential driver of IBC phenotypes. Here, using single-cell RNA sequencing, multiplex staining, and serum analysis in IBC patients, we identified enrichment of a subgroup of luminal progenitor (LP) cells containing high expression of the neurotropic cytokine pleiotrophin (PTN) in IBC tumors. PTN secreted by the LP cells promoted angiogenesis by directly interacting with the NRP1 receptor on endothelial tip cells located in both IBC tumors and the affected skin. NRP1 activation in tip cells led to recruitment of immature perivascular cells in the affected skin of IBC, which are correlated with increased angiogenesis and IBC metastasis. Together, these findings reveal a role for crosstalk between LPs, endothelial tip cells, and immature perivascular cells via PTN-NRP1 axis in the pathogenesis of IBC, which could lead to improved strategies for treating IBC.
基金:
This study was supported by the National Key Research and Development Program
(2021YFE0206300),the National Natural Science Foundation of China (82372781),
and the Beijing Science and Technology Innovation Medical Development
Foundation (KC2021-JX-0044-11).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2023]版:
大类|1 区医学
小类|2 区肿瘤学
最新[2025]版:
大类|1 区医学
小类|1 区肿瘤学
第一作者:
第一作者机构:[1]Breast Disease Center, The First Affiliated Hospital, Sun Yat-sen University,Guangzhou, China
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Zhang Mengmeng,Zhou Kaiwen,Wang Zilin,et al.A subpopulation of luminal progenitors secretes pleiotrophin to promote angiogenesis and metastasis in inflammatory breast cancer[J].Cancer Research.2024,doi:10.1158/0008-5472.CAN-23-2640.
APA:
Zhang Mengmeng,Zhou Kaiwen,Wang Zilin,Liu Ting,Stevens Laura E...&Lin Ying.(2024).A subpopulation of luminal progenitors secretes pleiotrophin to promote angiogenesis and metastasis in inflammatory breast cancer.Cancer Research,,
MLA:
Zhang Mengmeng,et al."A subpopulation of luminal progenitors secretes pleiotrophin to promote angiogenesis and metastasis in inflammatory breast cancer".Cancer Research .(2024)